14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
Please join our Eminent Domain & Valuation Group for a special webinar on “Navigating COVID-19 for ...
Read More >
As sophisticated employers know, an employer must track and comply with developments not only in fed...
Read More >
By now you have probably seen a number of articles about the SECURE Act (Setting Every Community Up ...
Read More >
On August 6, 2019, in State of Texas v. Equal Employment Opportunity Commission, the U.S. Court of A...
Read More >
Title VII of the Civil Rights Act of 1964 does not prohibit all harassing conduct. Rather, the haras...
Read More >
During college in the 1970s, I spent my summers working as a framer in residential construction; I w...
Read More >